Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

That’s not accurate. There were no animal studies performed against SARS-CoV-2, but there was extensive testing against EBOV among several virus types. There was also extensive human efficacy trials previously. It was approved primarily because the lack of effective treatment created a very low bar. This is similar to the case of Tamiflu initial approval against H5N1 when there was that worldwide scare.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214279/